Prestige Consumer Healthcare (PBH) EBT Growth (1y) (2011 - 2025)
Prestige Consumer Healthcare (PBH) EBT Growth (1y) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.05 Bn | 43.08 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.39 Bn | 39.74 Bn | 2.15 Bn | -324.14% |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | -5.04% |
| 4 | Takeda Pharmaceutical | 28.78 Bn | 22.99 Bn | 5.10 Bn | -1.93% |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | -8.74% |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 70.52% |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 1.69% |
| 8 | Elanco Animal Health | 11.92 Bn | 11.39 Bn | 798.00 Mn | 124.00% |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 9.99 Bn | - | - |
| 10 | Prestige Consumer Healthcare | 2.43 Bn | 2.36 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -22.88% |
| Sep 30, 2025 | -3.53% |
| Jun 30, 2025 | 5.76% |
| Mar 31, 2025 | 9.86% |
| Dec 31, 2024 | 15.21% |
| Sep 30, 2024 | 1.77% |
| Jun 30, 2024 | -14.99% |
| Mar 31, 2024 | 122.48% |
| Dec 31, 2023 | 2.14% |
| Sep 30, 2023 | 5.74% |
| Jun 30, 2023 | -3.08% |
| Mar 31, 2023 | -591.30% |
| Dec 31, 2022 | 4.01% |
| Sep 30, 2022 | 11.68% |
| Jun 30, 2022 | -7.17% |
| Mar 31, 2022 | 51.00% |
| Dec 31, 2021 | 22.02% |
| Sep 30, 2021 | 14.90% |
| Jun 30, 2021 | 31.29% |
| Mar 31, 2021 | -20.11% |